Added to YB: 2023-08-02
Pitch date: 2023-08-02
ADCT:US [bullish]
ADC Therapeutics SA
+183.89%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
ADC Therapeutics SA focuses on advancing its proprietary antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.
Market Cap
$154.7M
Pitch Price
$1.49
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.42
P/E
-0.69
EV/Sales
4.73
Sector
Biotechnology
Category
N/A
Show full summary:
ADC Therapeutics Ltd ADCT:US
A summary for this pitch has not been created yet.
Read full article (0 min)